NFKB1 and Alzheimer disease: Among the 10 TLRs identified in humans (TLR1–TLR10), TLR4 has been particularly implicated in AD pathophysiology due to its capacity to recognize Aβ and initiate downstream signaling cascades involving nuclear factor-kappa B (NF-κB), ultimately leading to pro-inflammatory gene expression [11, 12].